Skip to content
healthcare.dev

Darunavir

NDC 59651-085, Darunavir, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
59651-085
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210677
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-085 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARUNAVIR PROPYLENE GLYCOLATE600 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]

Package NDCNDC-11Package
59651-085-605965100856060 TABLET, FILM COATED in 1 BOTTLE (59651-085-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/88910ad0-6dc3-4a47-8a6b-5c6ee79f2a93
  • NADAC price for package 59651008560

    GET /v1/drugs/nadac/59651008560

Use it

Look up 59651-085 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-085 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-085. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.